Vadira Ayuromedic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 6 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.34 Cr
as on 18-12-2024
About Vadira Ayuromedic
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.34 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Indu Sharma and Mahi Paliwal serve as directors at the Company.
- CIN/LLPIN
U51909RJ2018PTC063396
- Company No.
063396
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does Vadira Ayuromedic Private Limited offer?
Vadira Ayuromedic Private Limited offers a wide range of products and services, including Popular Category, Diabetes Care, Bone & Joint Care, Vitamins & Supplements, Multivitamins, Health Conditions, Liver Care, Women Care, Women Care Supplements, Fever.
Who are the key members and board of directors at Vadira Ayuromedic?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Indu Sharma | Director | 21-Dec-2018 | Current |
Mahi Paliwal | Director | 01-Nov-2021 | Current |
Financial Performance of Vadira Ayuromedic.
Vadira Ayuromedic Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Vadira Ayuromedic?
In 2023, Vadira Ayuromedic had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shreepachar Mines And Minerals LlpActive 1 year 9 months
Indu Sharma and Mahi Paliwal are mutual person
- Vadira Retailers Private LimitedActive 1 year 19 days
Indu Sharma and Mahi Paliwal are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 31 Dec 2020 | ₹1.34 Cr | Satisfied |
How Many Employees Work at Vadira Ayuromedic?
Unlock and access historical data on people associated with Vadira Ayuromedic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vadira Ayuromedic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vadira Ayuromedic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.